Amneal Pharmaceuticals (US:AMRX) — Company Overview, News & Financial Data
Amneal Pharmaceuticals specializes in developing generic and specialty pharmaceutical products across therapeutic areas.
About Amneal Pharmaceuticals
Amneal Pharmaceuticals (NASDAQ:AMRX) is a dynamic company specializing in the development, manufacture, and distribution of generic and specialty pharmaceutical products. Primarily focusing on a wide range of therapeutic areas, Amneal aims to provide high-quality medications that improve patient outcomes while striving to make healthcare more accessible. With a robust pipeline of products aimed at addressing complex diseases, the company is dedicated to innovation and expanding its portfolio to meet diverse healthcare needs. Amneal's objectives revolve around leveraging its R&D capabilities to fuel growth, fostering strategic partnerships, and ensuring environmental sustainability in its operations, aiming to create value for both patients and stakeholders.
Snapshot
Operations
Products and/or services of Amneal Pharmaceuticals
- Generic Pharmaceuticals: Producing high-quality generic pharmaceuticals across a variety of therapeutic areas.
- Specialty Pharmaceuticals: Focused on developing unique treatments for complex diseases.
- Biosimilars: Working on affordable alternatives to biologic drugs, emphasizing accessible healthcare.
- Over-the-Counter Medications: Offering a range of over-the-counter products for various health needs.
- Research and Development: Investing in innovative research to expand the pharmaceutical portfolio.
- Partnerships and Collaborations: Engaging with other firms for development and distribution of pharmaceuticals.
Amneal Pharmaceuticals executive team
- Mr. Chirag K. PatelCo-Founder, Co-CEO, President & Director
- Mr. Chintu Patel R.Ph.Co-Founder, Co-CEO & Director
- Mr. Anastasios G. KonidarisExecutive VP & CFO
- Mr. Jason B. Daly Esq.Executive VP, Chief Legal Officer & Corporate Secretary
- Ms. Nikita ShahExecutive VP & Chief Human Resources Officer
- Mr. Andrew S. BoyerExecutive VP and Chief Commercial Officer of Generics & Biosciences
- Mr. Anthony DiMeoHead of Investor Relations
- Mr. Gregory SgammatoSenior Vice President of Corporate Development
- Mr. Pranav MehtaSenior VP of Strategic Sourcing & Supply Management
- Dr. Sanjay Kumar Jain Ph.D.Chief Quality Officer